{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:46:37Z","timestamp":1791913597633,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Medical University of Gda\u0144sk","doi-asserted-by":"publisher","award":["01-10026\/0010396\/01\/221\/221\/0\/2026"],"award-info":[{"award-number":["01-10026\/0010396\/01\/221\/221\/0\/2026"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpsychires.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:01:59Z","timestamp":1789023719000},"page":"121-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical correlates of non-responders to ketamine in terms of self-assessed life engagement among treatment-resistant depression patients"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6105-1528","authenticated-orcid":false,"given":"Micha\u0142","family":"Walaszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw Jerzy","family":"Cuba\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Pastuszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Kachlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.09.003_bib1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12888-025-06826-z","article-title":"Work re-entry and functioning in people with major depression: a longitudinal study of supported employment participants","volume":"25","author":"Bergdolt","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamapsychiatry.2022.0100","article-title":"Socioeconomic indicators of treatment prognosis for adults with depression","volume":"79","author":"Buckman","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jad.2020.11.045","article-title":"Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: post hoc pooled analyses of randomized placebo-controlled and open-label trials","volume":"281","author":"Chen","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jad.2025.04.119","article-title":"The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: a systematic review","volume":"382","author":"Cheng","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1745017901107010140","article-title":"Differences between early and late onset adult depression","volume":"7","author":"Drachmann Bukh","year":"2011","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jad.2020.07.109","article-title":"The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials","volume":"276","author":"Fornaro","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib9","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/dep.2025.10001","article-title":"Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups","volume":"2","author":"Hopwood","year":"2025","journal-title":"Res. Directions: Depression"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpsychires.2025.10.056","article-title":"The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: a systematic review","volume":"192","author":"Ji","year":"2026","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70038","article-title":"Nonresponse to ketamine in treatment\u2010resistant bipolar depression","volume":"45","author":"Kachlik","year":"2025","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/20451253251412629","article-title":"Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depression","volume":"16","author":"Kachlik","year":"2026","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104171","article-title":"A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression","volume":"99","author":"Kumar","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.euroneuro.2024.04.014","article-title":"Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review","volume":"86","author":"Kwa\u015bny","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116355","article-title":"Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: a systematic review","volume":"345","author":"Lima Constantino","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment\u2010resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/JCP.16m10744","article-title":"Efficacy of vortioxetine on cognitive functioning in working patients with major depressive disorder","volume":"78","author":"McIntyre","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s41687-022-00468-5","article-title":"Patient-reported outcome measures for life engagement in mental health: a systematic review","volume":"6","author":"McIntyre","year":"2022","journal-title":"J. Patient-Rep. Outcomes"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15622975.2023.2169349","article-title":"Oral ketamine for depression: an updated systematic review","volume":"24","author":"Meshkat","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib20","article-title":"Bipolar disorders: an update on critical aspects","volume":"48","author":"Oliva","year":"2025","journal-title":"The Lancet Reg. Health - Eur."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jad.2024.01.228","article-title":"Possible role of metformin as an antidepressant in diabetes","volume":"351","author":"Pedrea\u00f1ez","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib22","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2025.10123","article-title":"Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release","volume":"68","author":"Reif","year":"2025","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113860","article-title":"The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: results from the canadian rapid treatment center of excellence","volume":"300","author":"Rodrigues","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2018.09.027","article-title":"Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression","volume":"243","author":"Rosenblat","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib25","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.4088\/JCP.15com09859","article-title":"Distinguishing functional from syndromal recovery: implications for clinical care and research","volume":"76","author":"Rush","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41398-025-03255-0","article-title":"Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review","volume":"15","author":"Sajid","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110268","article-title":"Copper and anti-anhedonic effect of ketamine in treatment-resistant depression","volume":"144","author":"S\u0142upski","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpsychires.2023.02.008","article-title":"Assessment of patient life engagement in major depressive disorder using items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR)","volume":"161","author":"Thase","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 13","key":"10.1016\/j.jpsychires.2026.09.003_bib31","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.euroneuro.2024.12.013","article-title":"Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: findings from a 32-week randomised, open-label, rater-blinded phase IIIb study","volume":"93","author":"Vieta","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bdi.70048","article-title":"Defining treatment\u2010resistant bipolar depression: recommendations from the <scp>ISBD<\/scp> task force","volume":"27","author":"Vieta","year":"2025","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s43440-025-00730-9","article-title":"Non-response to short-term ketamine use for treatment-resistant depression","volume":"77","author":"Walaszek","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121762","article-title":"Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depression","volume":"407","author":"Walaszek","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s41687-021-00380-4","article-title":"Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews","volume":"5","author":"Weiss","year":"2021","journal-title":"J. Patient-Rep. Outcomes"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314605","article-title":"The downstaging concept in treatment-resistant depression: spotlight on ketamine","volume":"23","author":"Wilkowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.09.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2026.104870","article-title":"Molecular evidence associating GLP-1 receptor agonists and brain-derived neurotrophic factors in neurodegenerative and psychiatric disorders: a systematic review","volume":"117","author":"Xu","year":"2026","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/a-2179-8884","article-title":"Factors associated with antidepressant effects of ketamine: a reanalysis of double-blind randomized placebo-controlled trial of intravenous ketamine for treatment-resistant depression","volume":"57","author":"Yonezawa","year":"2024","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.003_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jpsychires.2007.09.004","article-title":"Remission in depressed outpatients: more than just symptom resolution?","volume":"42","author":"Zimmerman","year":"2008","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:16Z","timestamp":1791910696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626004395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0022395626004395"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.09.003","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical correlates of non-responders to ketamine in terms of self-assessed life engagement among treatment-resistant depression patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}